Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2014
Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancyFlor M Munoz, Leonard E Weisman, Jennifer S Read, et al.
Vaccine|September 21, 2014
Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adultsDavid I Bernstein, Lisa Jackson, Shital M Patel, et al.
The Journal of Infectious Diseases|February 12, 2008
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adultsDavid I Bernstein, Kathryn M Edwards, Cornelia L Dekker, et al.
The Journal of Infectious Diseases|November 21, 2013
Determination of the 50% human infectious dose for Norwalk virusRobert L Atmar, Antone R Opekun, Mark A Gilger, et al.
Clinical and Vaccine Immunology : CVI|November 13, 2015
Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 AdjuvantWilbur H Chen, Lisa A Jackson, Kathryn M Edwards, et al.
Vaccine|August 7, 2013
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspASharon E Frey, Kathleen R Lottenbach, Heather Hill, et al.
Vaccine|August 26, 2011
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccineRobert L Atmar, Wendy A Keitel, John M Quarles, et al.
Open Forum Infectious Diseases|March 4, 2015
Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 AdjuvantWilbur H Chen, Lisa A Jackson, Kathryn M Edwards, et al.
Vaccine|November 27, 2007
Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challengeSharon E Frey, Frances K Newman, Jeffrey S Kennedy, et al.
Clinical & Translational Immunology|January 28, 2021
Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisationRosangela Salerno-Gonçalves, Wilbur H Chen, Mark J Mulligan, et al.
Pageof 7